Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 351

PDF Downloaded: 195


Get Permission Singh, Harsolia, and Porwal: Study of visual outcome and complications of primary and secondary retropupillary iris claw lens implantation in absence of adequate capsular support


Introduction

Cataract’ is in fact the most common cause of blindness if untreated.1 This disorder involves the unclear opacified lens which obscures the passage of light; hence this progressive disorder requires treatment.2, 3, 4, 5, 6 Its global prevalence is 15.2 million people became blind and 78.8 million people remained visually impaired. Posterior capsular rent is one of the potential complications of cataract surgery. Which was seen to occur in 0.45%–5.2% of cases.7, 8 Cataract surgery can result in adverse outcome in case of an improperly managed Posterior capsular rent. Patients who are left aphakic are visually impaired without glasses which result in increased prevalence of blindness which is not treatable. Thus, cataract surgery won’t reduce the prevalence of blindness. ‘Loss of vitreous’ is most important factor which determines the visual acuity in post-surgery scenerio. 9

Primary Iris claw implantation means that the IC-IOL which is to be implanted, is done in the same sitting after cataract removal. While secondary Iris claw lens implant is done in aphakic eyes without capsular support and can be done post cataract surgeries (In the second sitting) when the eye is left aphakic due to complications like lens drop/nucleus drop/vitreous loss occurred because of posterior capsular rupture.10

Because of its peculiar means of fixation, to the mid peripheral iris, the IC-IOL implantation can be done in any eye with sufficient support to iris. In addition, the iris claw lenses are much better than angle-supported Anterior chamber lenses when compared in terms of endothelial cell loss. IC-IOL placement can be done either anterior to the iris or can be retro fixated. An anterior fixated IC-IOL may show many complications, like those caused by AC-IOL, for example endothelial decompensation. Therefore, most of the surgeons like to prefer retropupillary fixation of IC-IOL so as to enhance endothelial safety. Hereby, in this study we have compared the outcomes of primary and secondary retropupillary fixated iris claw lenses.

Conventional secondary IOL implantation via scleral sutures is the treatment of choice, as the position of the scleral-fixated IOL (SF-IOL) is also ideal with respect to the anatomy of the eye. However, this technique necessitates the use of sutures and sufficient operative experience, and has a longer surgical time.7 Secondary IOL scleral fixation can also lead to other severe intraocular complications, such as vitreous hemorrhage, retinal detachment, choroidal detachment, and suture-related complications.8

This RPICL implantation technique also gained popularity after Mohr et al. released the 1-year clinical outcomes for this technique in 2008.9 Structurally, RPICL provides better stability and lowers the risks of IOL tilt or dislocation as compared to iris- or scleral-sutured lenses. Further, the absence of sutures for IOL scleral fixation lowers the risk of suture-related complications, like conjunctival erosion, scleromalacia, and endophthalmitis.10, 11 Many previous studies have also supported the secondary RPICL to be a safe and efficacious technique for correcting various aphakic conditions with12, 13, 14, 15, 16, 17, 18 or without IOL dislocation.7, 19

Materials and Methods

This prospective study was conducted after taking an informed consent from patients or their relatives who was attending the OPD in Department of Ophthalmology, J.L.N. Medical College and Associated group of Hospitals, Ajmer (Raj.) over a period of 18 months (Oct. 2020 to March 2022) after obtaining ethical committee approval.

Inclusion criteria

  1. All patients of Surgical aphakia during surgery with no capsular support due to posterior capsular rupture in an extracapsular cataract extraction surgery (SICS/Phaco) where PCIOL implantation was not possible to implant (primary cases).

  2. All patients of traumatic, surgical aphakia or subluxated PCIOL (secondary cases).

Exclusion criteria

  1. Patients having no perception of light (PL) and defective projection of rays (PR) in traumatic cataract

  2. Significant iris pathology

  3. Glaucoma

  4. Chronic or recurrent uveitis/iritis

  5. Severe diabetic eye disease

  6. Corneal pathology: Corneal scarring, irregularities, or opacities

All patients were investigated thoroughly, and proper consent was taken.

Study design

This study was a hospital based, prospective, interventional, clinical study conducted in a tertiary eye care centre. We studied the secondary iris-claw IOL implantation in 60 patients who fulfilled the criteria discussed above, over a period of 24 months. All patients were thoroughly investigated before undergoing secondary iris-claw lens implantation. Post-operatively, best-corrected visual acuity (BCVA), intraocular pressure (IOP) and complication encountered were noted at a regular follow-up of immediate post-operatively, 1 week, 1 month, 2 month & 3 months. 60 eyes of 60 patients in which 30 patients with primary retropupillary iris claw lens and 30 with secondary retropuillary iris claw lens fulfilled the above mentioned criteria. (Figure 3, Figure 4)

Results

  1. Group I: Primary cases

  2. Group II: Secondary cases

Distant vision (BCVA) at 3rd month follow up: The BCVA in both group I and group II was noted during the 3rd month follow-up, it was observed that, 1 (3.3%) and 26 (86.7) patients had 6/12 to 6/6visual acuity from group I and group II cases respectively. Similarly, 6 (20%) patients had BCVA between 3/60 to 6/60 in group I but none of the patients were in group II. In group I and group II cases, 23 (76.7%) and 4 (13.3%) patients respectively had BCVA between 6/36 to 6/18.

Graph 1

Distant vision (BCVA) at presentation

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/373c4fb5-fae5-49c1-b148-3e73175e28faimage3.png

Graph 2

Various complications at presentation

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/373c4fb5-fae5-49c1-b148-3e73175e28faimage4.png

Figure 1

Showing ovalization of pupil 3rd month follow up after secondary retropupillary iris claw lens implantation

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/373c4fb5-fae5-49c1-b148-3e73175e28faimage5.png
Figure 2

Showing tilted IOL with raised IOP 3rd month follow up after primary retropupillary iris claw lens implantation

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2bf1c3ff-3869-4c9e-9a29-8cd795ada850/image/ffd5c29a-d1cd-4340-8edc-1eb3d2e30564-u1.png

Various complications in group I and group II at 3rd month follow up: Complications were documented at 3rd month follow-up from each patient from group I and group II cases; it was observed that, high refractive surprise was found in high in 8(26.67%) patients in group II and 6 (20%) patients in group I. Ovalisation of pupil was found in 6 (20%) patients in group I and 1(3.33%) patient in group II. Raised IOP was also noticed in 4 (13.33%) and 2 (6.67%) patients from group I and group II respectively. Optic capture was found in 3(10%) and 2 (6.67%) patients from group I and group II respectively. Displaced/Tilted IOL with raised IOP, Iridodialysis and Bullous Keratopathy were found in 3(10%) patients from group I but none were found in group II. Further, CME was noticed in 2 (6.67%) and 1(3.33%) patient from group I and group II. Iridodialysis with raised IOP and CME with raised IOP were noticed only in 1(.33%) patient from group II, but none were found in group I.

Overall data has conferred a statistical significance with P value of 0.001 in both groups.(Figure 1, Figure 2)

Discussion

In observational study done by Ashwini R Mahajan et al20 (2014) found that, 73.4% patients with ICIOL were having final BCVA 6/18 to 6/6 and 23.33% ICIOL patient were having BCVA between 6/60 to 6/24 group which is in accordance with our study results in secondary cases and higher than our study results in primary cases.

In observational study done by Navya C et al21 (2020) found final BCVA 6/18 to 6/6 in 86.67% cases which is in accordance with our study results in secondary cases and higher than our study results in primary cases.

In observational study done by Kanekar et al22 (2020) found BCVA from 6/18 to 6/6 in 85% cases which is in accordance with our study results in secondary cases and higher than our study results in primary cases.

Ravindra et al (1994)23 reported a BCVA of 6/18 or better in 80.7% cases which is in accordance with our study results in secondary cases and higher than our study results in primary cases.

In a cross-sectional observational study done by Trivedi K et al (2021)24 found that, nearly 39.62% eyes had best-corrected visual acuity in the range of 6/18–6/36, which is lower than our study results in primary cases and higher than our study

In observational study done by Gonnermann et al25 (2012) ovalization of pupil was found in 24.8% cases, which was found in accordance with our study results in primary cases and lower than our study results in secondary cases. Tilted IOL in 8.7% cases, which is in accordance with our study result in primary cases CME in 8.7% cases which are in accordance with our study result in both primary and secondary cases.

In observational study done by Kalode V et al26 (2019) ovalization of pupil found in 12% cases which is lower than our study results in primary group and higher than our study result in secondary group.

In observational study done by Shanida HS et al27 (2018), optic capture found in 6.6% cases which is lower than our study result in primary cases and in accordance with our study results in secondary cases.

In observational study done by Sumita CV et al17 (2020), pseudophakic bullous keratopathy found in 16.7% cases, which is higher than in our study results in both primary and secondary cases. Tilted IOL in 11.1% cases which is in accordance in our study results in primary cases and higher than our study results in secondary cases. 25% cases having ovalization of pupil which is in accordance our study result in primary cases results and higher than our study results in secondary cases.

Conclusion

Results of present study suggest that secondary cases (group II) showed better visual outcome and lesser complications when compared with primary cases (group I) after retropupillary iris claw lens implantation.

Source of Funding

None.

Conflict of Interest

None.

References

1 

GS Bettadapura K Donthi NP Datti BG Ranganath SB Ramaswamy TS Jayaram Assessment of avoidable blindness using the rapid assessment of avoidable blindness methodologyN Am J Med Sci20124938993

2 

AA Nizami AC Gulani Cataract Cataract. [Updated 2022 Jul 5]StatPearls [Internet]Treasure Island (FL): StatPearls Publishing2022

3 

GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study Lancet Glob Health202192e1446010.1016/S2214-109X(20)30489-7.

4 

National Blindness and Visual Impairment Survey India 2015-20192015https://npcbvi.gov.in/writeReadData/mainlinkFile/File341.pdf[Accessed on 24 July 2021]

5 

India Ophthalmology Devices Market Report 2022: Technological Advancements in the Field of Ophthalmology Driving Growth - ResearchAndMarkets.com2022https://www.businesswire.com/news/home/20220727005644/en/India-Ophthalmology-Devices-Market-Report-2022-Technological-Advancements-in-the-Field-of-Ophthalmology-Driving-Growth---ResearchAndMarkets.com[July 27, 2022]

6 

India National Census. Census of India 2011 [Internet]. New Delhi: Indian National Census2011www.censusindia. gov.in/2011-Common/CensusData2011.html[Cited 2019, June 23]

7 

RB Vajpayee N Sharma T Dada V Gupta A Kumar VK Dada Management of posterior capsule tearsSurv Ophthalmol202145647388

8 

PB Greenberg VL Tseng WC Wu J Liu L Jiang CK Chen Prevalence and predictors of ocular complications associated with cataract surgery in United States veteransOphthalmology201111835071410.1016/j.ophtha.2010.07.023

9 

A Mohr F Hengerer C Eckardt Retropupillary fixation of the iris claw lens in aphakia. 1 year outcome of a new implantation techniquesOphthalmologe2002997580310.1007/s00347-001-0563-z

10 

YY Kwong HKL Yuen RF Lam VYW Lee SK Rao DSC Lam Comparison of outcomes of primary scleral-fixated versus primary anterior chamber intraocular lens implantation in complicated cataract surgeriesOphthalmology20071141805

11 

P Sen V Kumar P Sen P Bhende P Rishi E Rishi Surgical outcomes and complications of sutured scleral fixated intraocular lenses in pediatric eyesCan J Ophthalmol2018531495510.1016/j.jcjo.2017.07.015

12 

M Brandner S Thaler-Saliba S Plainer B Vidic Y El-Shabrawi N Ardjomand Retropupillary fixation of iris-claw intraocular lens for aphakic eyes in childrenPLoS ONE2015106e0126614 10.1371/journal.pone.0126614

13 

M Forlini W Soliman A Bratu P Rossini GM Cavallini C Forlini Long-term follow-up of retropupillary iris-claw intraocular lens implantation: a retrospective analysisBMC Ophthalmol20151514310.1186/s12886-015-0146-4

14 

O Kristianslund M Raen A E Ostern L Drolsum Late in-the-bag intraocular lens dislocation: A randomized clinical trial comparing lens repositioning and lens exchangeOphthalmology201712421519

15 

MD Toro A Longo T Avitabile K Nowomiejska C Gagliano S Tripodi Five-year follow-up of secondary iris-claw intraocular lens implantation for the treatment of aphakia: Anterior chamber versus retropupillary implantationPLoS ONE2019144e021414010.1371/journal.pone.0214140

16 

N Madhivanan S Sengupta M Sindal PD Nivean MA Kumar M Ariga Comparative analysis of retropupillary iris claw versus scleral-fixated intraocular lens in the management of post-cataract aphakiaIndian J Ophthalmol20196715963

17 

CV Sumitha V Pai M Thulasidas Retropupillary iris-claw intraocular lens implantation in aphakic patientsIndian J Ophthalmol2020684597602

18 

T Mansoori SG Agraharam S Sannapuri S Manwani N Balakrishna Surgical outcomes of retropupillary-fixated iris-claw intraocular lensJ Curr Ophthalmol20203221495310.4103/JOCO.JOCO_92_20

19 

R Rao A Sasidharan Iris claw intraocular lens: A viable option in monocular surgical aphakiaIndian J Ophthalmol201361274510.4103/0301-4738.107198

20 

AR Mahajan NP Datti Comparison of iris claw lens and scleral fixated intraocular lens in terms of visual outcome and complicationsJ Clin Biomed Sci20144435760

21 

C Navya AS Hatti Comparative study of secondary implantation of iris-claw lens and scleral-fixation intraocular lens in terms of visual outcome and complicationsJ Clin Ophthalmol Res202081003

22 

PS Kanekar S Patare D Naik omparative analysis of secondary implantation of Iris claw intraocular lens (ICIOL) & Scleral fixated intraocular lens (SFIOL) in terms of visual outcome and complicationsVIMS Health Sci J2020741107

23 

B Ravindra AK Mallik Role of nonlinear dissipation in soft Duffing oscillatorsPhys Rev E199449649504

24 

K Trivedi S Koley Mathematical modeling of breakwater-integrated oscillating water column wave energy converter devices under irregular incident wavesRenewable Energy202117840319

25 

J Gonnermann MKJ Klamann AK Maier J Rjasanow AM Joussen E Bertelmann Visual outcome and complications after posterior iris-claw aphakic intraocular lens implantationJ Cataract Refract Surg20123812213942

26 

V Kalode S Daigavane Study of visual outcome and complications of iris-claw intraocular lens implantation to correct aphakiaJ Datta Meghe Inst Med Sci Univ201914314154

27 

HS Shanida S Narayan K C Rajini Visual outcome and complications of posterior iris-claw intraocular lens implantation: A follow-up analysisKerala J Ophthalmol20183010711



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

413-417


Authors Details

Paramveer Singh*, Ramswaroop Harsolia, Rakesh Porwal


Article History

Received : 30-04-2023

Accepted : 24-05-2023


Article Metrics


View Article As

 


Downlaod Files